Main > GASTROENTEROLOGY > Inflammatory Bowel Disease (IBD) > Treatment > DHODH Inhibitor (Vidofludimus) > Co.: DE. 4. Phase IIA

---

Co.: DE. 4. Phase IIA's subsections
Company
DHODH: DiHydroOrotate DeHydrogenase
Patent>Asignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 01.22.2013
UpDate: 11.02.2012

Co.: DE. 4. Phase IIA's products
This section has no products